These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 1365682)

  • 21. Trends in incidence rates of invasive lobular and ductal breast carcinoma.
    Li CI; Anderson BO; Daling JR; Moe RE
    JAMA; 2003 Mar; 289(11):1421-4. PubMed ID: 12636465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. National treatment trends for ductal carcinoma in situ of the breast.
    Winchester DJ; Menck HR; Winchester DP
    Arch Surg; 1997 Jun; 132(6):660-5. PubMed ID: 9197860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relation between the presence and extent of lobular carcinoma in situ and the risk of local recurrence for patients with infiltrating carcinoma of the breast treated with conservative surgery and radiation therapy.
    Abner AL; Connolly JL; Recht A; Bornstein B; Nixon A; Hetelekidis S; Silver B; Harris JR; Schnitt SJ
    Cancer; 2000 Mar; 88(5):1072-7. PubMed ID: 10699897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nipple Preservation in Breast Cancer Associated with Nipple Discharge.
    Chang RY; Cheung PS
    World J Surg; 2017 Jan; 41(1):176-183. PubMed ID: 27501708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In situ breast cancer.
    Henry-Tillman RS; Klimberg VS
    Curr Treat Options Oncol; 2000 Aug; 1(3):199-209. PubMed ID: 12057162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast disease: a primer on diagnosis and management.
    Drukker BH
    Int J Fertil Womens Med; 1997; 42(5):278-87. PubMed ID: 9406832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of local treatment on the recurrence rate of ductal carcinoma in situ.
    Warneke J; Grossklaus D; Davis J; Stea B; Bebb G; Taylor C; Hastings R; Villar H
    J Am Coll Surg; 1995 Jun; 180(6):683-8. PubMed ID: 7773481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology of in situ and invasive breast cancer in women aged under 45.
    Weiss HA; Brinton LA; Brogan D; Coates RJ; Gammon MD; Malone KE; Schoenberg JB; Swanson CA
    Br J Cancer; 1996 May; 73(10):1298-305. PubMed ID: 8630296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Metachronous tumors of the breast. Mammographic findings].
    Tella S; Occhiato R; Speziale AM; Poggi R; Grasso F; Frasca F; Passariello R
    Radiol Med; 1994 Mar; 87(3):245-9. PubMed ID: 8146360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Christchurch Breast Cancer Patient Register: the first year.
    Davey V; Robinson B; Dijkstra B; Harris G
    N Z Med J; 2012 Aug; 125(1360):37-47. PubMed ID: 22932653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contralateral breast cancer: incidence according to ductal or lobular phenotype of the primary.
    Langlands F; White J; Kearins O; Cheung S; Burns R; Horgan K; Sharma N; Dodwell D
    Clin Radiol; 2016 Feb; 71(2):159-63. PubMed ID: 26703116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lobular neoplasia: morphology and management.
    Jorns J; Sabel MS; Pang JC
    Arch Pathol Lab Med; 2014 Oct; 138(10):1344-9. PubMed ID: 25268198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)?
    Lakhani SR; Audretsch W; Cleton-Jensen AM; Cutuli B; Ellis I; Eusebi V; Greco M; Houslton RS; Kuhl CK; Kurtz J; Palacios J; Peterse H; Rochard F; Rutgers E;
    Eur J Cancer; 2006 Sep; 42(14):2205-11. PubMed ID: 16876991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
    Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM
    Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast carcinoma in situ in 167 women--incidence, mode of presentation, therapy and follow-up.
    Ringberg A; Andersson I; Aspegren K; Linell F
    Eur J Surg Oncol; 1991 Oct; 17(5):466-76. PubMed ID: 1657650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Breast cancer in males: a study of 15 cases of pure ductal carcinoma in situ].
    Cutuli BF; Florentz P; Lacroze M; Dilhuydy JM; Allavena C; De Lafontan B; Resbeut M; Campana F; Graic Y; Tortochaux J
    Bull Cancer; 1992; 79(11):1045-53. PubMed ID: 1338868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CE-Magnetic Resonance Mammography for the evaluation of the contralateral breast in patients with diagnosed breast cancer.
    Pediconi F; Venditti F; Padula S; Roselli A; Moriconi E; Giacomelli L; Catalano C; Passariello R
    Radiol Med; 2005; 110(1-2):61-8. PubMed ID: 16163140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Breast lobular carcinoma in situ: diagnosis and evolution].
    Espié M; Hocini H; Cuvier C; Giacchetti S; Bourstyn E; de Roquancourt A
    Gynecol Obstet Fertil; 2005 Dec; 33(12):964-9. PubMed ID: 16324870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidental atypical proliferative lesions in reduction mammoplasty specimens: analysis of 2498 cases from 2 tertiary women's health centers.
    Desouki MM; Li Z; Hameed O; Fadare O; Zhao C
    Hum Pathol; 2013 Sep; 44(9):1877-81. PubMed ID: 23656973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of ductal carcinoma in situ.
    Vezeridis MP; Bland KI
    Surg Oncol; 1994 Dec; 3(6):309-25. PubMed ID: 7773449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.